Targeting AAV vectors to the central nervous system by engineering capsid–receptor interactions that enable crossing of the blood–brain barrier
PLOS Biology · 19.07.2023 · 21 (7) · e3002112
DOI: 10.1371/journal.pbio.3002112 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 19.07.2023. Verfasst von Qin Huang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Capsid. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIMH NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Viruses have evolved the ability to bind and enter cells through interactions with a wide variety of cell macromolecules. We engineered peptide-modified adeno-associated virus (AAV) capsids that transduce the brain through the introduction of de novo interactions with 2 proteins expressed on the mouse blood–brain barrier (BBB), LY6A or LY6C1. The in vivo tropisms of these capsids are predictable as they are dependent on the cell- and strain-specific expression of their target protein. This approach generated hundreds of capsids with dramatically enhanced central nervous system (CNS) tropisms within a single round of screening in vitro and secondary validation in vivo thereby reducing the use of animals in comparison to conventional multi-round in vivo selections. The reproducible and quantitative data derived via this method enabled both saturation mutagenesis and machine learning (ML)-guided exploration of the capsid sequence space. Notably, during our validation process, we determined that nearly all published AAV capsids that were selected for their ability to cross the BBB in mice leverage either the LY6A or LY6C1 protein, which are not present in primates. This work demonstrates that AAV capsids can be directly targeted to specific proteins to generate potent gene delivery vectors with known mechanisms of action and predictable tropisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
- Biological and Biomedical Sciences, Harvard University, Cambridge, Massachusetts, United States of America.
- Electrical & Computer Engineering Department, Northeastern University, Boston, Massachusetts, United States of America.
- Department of Systems and Computer Engineering, Al-Azhar University, Cairo, Egypt.
- Department of Integrative Physiology, Baylor College of Medicine, Houston, Texas, United States of America.
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America.
ORCID-Profile: Benjamin E Deverman
Förderung
- NIH HHS
- NIMH NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- Stanley Center for Psychiatric Research, Broad Institute
- Apertura Gene Therapy
- National Institute of Mental Health
- Broad Institute Shark Tank Award
Zitieren
APA
Huang, Q., Chen, A. T., Chan, K. Y., Sorensen, H., Barry, A. J., Azari, B., Zheng, Q., Beddow, T., Zhao, B., Tobey, I. G., Moncada-Reid, C., Eid, F. E., Walkey, C. J., Ljungberg, M. C., Lagor, W. R., Heaney, J. D., Chan, Y. A., & Deverman, B. E. (2023). Targeting AAV vectors to the central nervous system by engineering capsid–receptor interactions that enable crossing of the blood–brain barrier. PLOS Biology, 21(7), e3002112. https://doi.org/10.1371/journal.pbio.3002112
Vancouver
Huang Q, Chen AT, Chan KY, Sorensen H, Barry AJ, Azari B, et al. Targeting AAV vectors to the central nervous system by engineering capsid–receptor interactions that enable crossing of the blood–brain barrier. PLOS Biology. 2023;21(7):e3002112. doi:10.1371/journal.pbio.3002112
BibTeX
@article{Huang2023,
author = {Huang, Qin and Chen, Albert T and Chan, Ken Y and Sorensen, Hikari and Barry, Andrew J and Azari, Bahar and Zheng, Qingxia and Beddow, Thomas and Zhao, Binhui and Tobey, Isabelle G and Moncada-Reid, Cynthia and Eid, Fatma-Elzahraa and Walkey, Christopher J and Ljungberg, M Cecilia and Lagor, William R and Heaney, Jason D and Chan, Yujia A and Deverman, Benjamin E},
title = {Targeting AAV vectors to the central nervous system by engineering capsid–receptor interactions that enable crossing of the blood–brain barrier},
journal = {PLOS Biology},
year = {2023},
volume = {21},
number = {7},
pages = {e3002112},
doi = {10.1371/journal.pbio.3002112}
}
EUVIMED